Effects of Dapagliflozin on Obese Patients With Type 2 Diabetes: A Prospective Observational Study From Bangladesh
Dapagliflozin appears to be an effective therapeutic option for the management of type 2 diabetes in obese individuals, contributing to improvements in glycemic control and metabolic parameters. When administered alone or in combination with other antidiabetic agents, it was associated with favorable clinical outcomes and an acceptable safety profile, supporting its utility in routine clinical practice.
Authors
- Ruma Akhter
- Laila Shamima Sharmin
- Somya Binte Akhond
- Jamila Bupasha
- Gull E Jannat
- Md Nazmul Hossain Sumon
- Fahim Mahbub
Institutions
- Bangladesh University (BD)
- Massachusetts General Hospital (US)
- Bangladesh University of Health Sciences (BD)
- Primary HealthCare (MT)
- Royal Victoria Hospital (GB)
- Central College (US)
- Dhaka Medical College and Hospital (BD)
Publication Details
- Journal
- Cureus
- Published
- 2025-08-04
- DOI
- https://doi.org/10.7759/cureus.89360
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00